UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD26 and Cancer

Cancers, 2022-10, Vol.14 (21), p.5194

Cordero, Oscar J

2022

Volltextzugriff (PDF)

On the origin of serum CD26 and its altered concentration in cancer patients

Cancer Immunology, Immunotherapy, 2009-11, Vol.58 (11), p.1723-1747

2009

Volltextzugriff (PDF)

Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy

Cancers, 2024-06, Vol.16 (13), p.2427

2024

Volltextzugriff (PDF)

The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

IUBMB life, 2021-05, Vol.73 (5), p.761-773

2021

Volltextzugriff (PDF)

Oral hygiene might prevent cancer

Heliyon, 2018-10, Vol.4 (10), p.e00879-e00879, Article e00879

2018

Volltextzugriff (PDF)

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis

PloS one, 2015-07, Vol.10 (7), p.e0131992-e0131992

2015

Volltextzugriff (PDF)

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

Disease markers, 2020, Vol.2020, p.4347936-10

2020

Volltextzugriff (PDF)

Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

Cancers, 2022-09, Vol.14 (19), p.4563

2022

Volltextzugriff (PDF)

Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26 + cancer stem cells subsets

Biology open, 2019, Vol.8 (7)

2019

Volltextzugriff (PDF)

Improving colorectal cancer screening programs

World journal of gastroenterology : WJG, 2024-06, Vol.30 (22), p.2849

2024

Volltextzugriff (PDF)

Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

PloS one, 2014-09, Vol.9 (9), p.e107470-e107470

2014

Volltextzugriff (PDF)

Distinctive CD26 Expression on CD4 T-Cell Subsets

Biomolecules (Basel, Switzerland), 2021-10, Vol.11 (10), p.1446

2021

Volltextzugriff (PDF)

Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

Scientific reports, 2014-02, Vol.4 (1), p.3999-3999, Article 3999

2014

Volltextzugriff (PDF)

Correction: CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis

PloS one, 2015-09, Vol.10 (9), p.e0139535-e0139535

2015

Volltextzugriff (PDF)

Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

BMC cancer, 2010-06, Vol.10 (1), p.333-333, Article 333

2010

Volltextzugriff (PDF)

Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors

Immunobiology (1979), 2011-08, Vol.216 (8), p.942-946

2011

Volltextzugriff (PDF)

Potential of soluble CD26 as a serum marker for colorectal cancer detection

World journal of clinical oncology, 2011-06, Vol.2 (6), p.245-261

2011

Volltextzugriff (PDF)

Fifteen years of prothymosin alpha: contradictory past and new horizons

Peptides, 2000-09, Vol.21 (9), p.1433-1446

2000

Volltextzugriff (PDF)

Data on the interaction between prothymosin α and TLR4 may help to the design of new antiviral compounds

Journal of acquired immune deficiency syndromes (1999), 2011-04, Vol.56 (4), p.e110-e111

Cordero, Oscar J

2011

Volltextzugriff (PDF)

Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

The FASEB journal, 2019-05, Vol.33 (5), p.6390-6401

2019

Volltextzugriff (PDF)

Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis

Clinical chemistry and laboratory medicine, 2017-01, Vol.55 (1), p.73-81

2017

Volltextzugriff (PDF)

How the Measurements of a Few Serum Markers Can Be Combined to Enhance their Clinical Values in the Management of Cancer

Anticancer research, 2008-07, Vol.28 (4C), p.2333-2341

2008

Volltextzugriff (PDF)

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

Archivum Immunologiae et Therapiae Experimentalis, 2022-12, Vol.70 (1), p.12-12, Article 12

2022

Volltextzugriff (PDF)

Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

Clinical biochemistry, 2017-11, Vol.50 (16-17), p.903-910

2017

Volltextzugriff (PDF)

Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes

Archivum Immunologiae et Therapiae Experimentalis, 2017-08, Vol.65 (4), p.275-284

2017

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(93)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

CD26 and Cancer

On the origin of serum CD26 and its altered concentration in cancer patients

Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy

The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

Oral hygiene might prevent cancer

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26 + cancer stem cells subsets

Improving colorectal cancer screening programs

Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

Distinctive CD26 Expression on CD4 T-Cell Subsets

Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

Correction: CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis

Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors

Potential of soluble CD26 as a serum marker for colorectal cancer detection

Fifteen years of prothymosin alpha: contradictory past and new horizons

Data on the interaction between prothymosin α and TLR4 may help to the design of new antiviral compounds

Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis

How the Measurements of a Few Serum Markers Can Be Combined to Enhance their Clinical Values in the Management of Cancer

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes

Suchergebnisse filtern